Rahika 200 Mg Tablet 12

About Rahika 200 MG Tablet 12

Rahika 200 MG Tablet is predominantly used to manage metastatic non-small cell lung cancer (NSCLC) in adults. This remedial agent belongs to a group of medicines known as kinase inhibitors.

Besides its primary function, Rahika 200 MG Tablet is particularly effective for NSCLC patients with a specific mutation leading to mesenchymal-epithelial transition (MET) exon 14 skipping. This mutation triggers an abnormal protein that incites cancer cells to multiply uncontrollably. By obstructing the action of this abnormal protein, the medicine can slow down or halt the spread of lung cancer cells.

For optimal results, it's crucial to take this medicine orally as directed by your doctor. Be sure to inform your doctor about any pre-existing conditions or ongoing medications before starting this medicine. If you notice any side effects while on this medicine, notify your doctor immediately. Continue taking the medicine for the duration prescribed by your doctor.

Frequently Asked Questions (FAQs)

What is Rahika 200 MG Tablet used for?

It's used to manage metastatic non-small cell lung cancer in adults whose tumours have a specific mutation causing MET exon 14 skipping.

How does Rahika 200 MG Tablet work?

Rahika contains capmatinib, which targets and blocks the MET receptor tyrosine kinase, an abnormal protein that encourages cancer cell growth and survival.

How should I take Rahika 200 MG Tablet?

Rahika is taken orally, with or without food. The tablets should be swallowed whole and not split, chewed, or crushed. Always follow your doctor's instructions for taking this medicine.

What are some common side effects of Rahika 200 MG Tablet?

Common side effects may include nausea, diarrhoea, fatigue, decreased appetite, muscle pain, swelling in limbs, and rashes.

What precautions should I take before starting Rahika 200 MG Tablet?

Inform your doctor about any pre-existing lung diseases, liver disorders or history of pancreatitis. Women who are pregnant or planning pregnancy should not take this medicine.

Does Rahika 200 MG Tablet interact with other medication?

Yes, co-administration with certain medicines like rifampicin, ketoconazole and phenytoin can affect capmatinib levels in your body. Always inform your doctor about all medicines you're currently taking.

How should I store Rahika 200 MG Tablet?

Store it at room temperature, away from light and moisture. Keep it out of reach of children and pets. Dispose of unused or expired medicine properly.

References

DailyMed. (n.d.). RAHIKA- tablet. U.S. National Library of Medicine. Retrieved 1 April 2024, from https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=455892c3-d144-4ba8-9ab4-79cabff9876d&audience=consumer
U.S. Food and Drug Administration. (n.d.). Drug approval package. U.S. Department of Health and Human Services. Retrieved 1 April 2024, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/213591s011lbl.pdf
National Center for Biotechnology Information (2024). PubChem Compound Summary for CID 25145656, Capmatinib. Retrieved November 27, 2024 from https://pubchem.ncbi.nlm.nih.gov/compound/Capmatinib
Wolf, J., Seto, T., Han, J. Y., Reguart, N., Garon, E. B., Groen, H. J. M., Tan, D. S. W., Hida, T., de Jonge, M., Orlov, S. V., Smit, E. F., Souquet, P. J., Vansteenkiste, J., Hochmair, M., Felip, E., Nishio, M., Thomas, M., Ohashi, K., Toyozawa, R., Overbeck, T. R., … GEOMETRY mono-1 Investigators (2020). Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer. The New England journal of medicine, 383(10), 944–957. https://doi.org/10.1056/NEJMoa2002787
Dhillon S. (2020). Capmatinib: First Approval. Drugs, 80(11), 1125–1131. https://doi.org/10.1007/s40265-020-01347-3

Disclaimer

We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.